Average Co-Inventor Count = 8.91
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Proteotech Inc. (5 from 28 patents)
2. Victoria Link Limited (3 from 52 patents)
3. Otago Innovation Limited (2 from 21 patents)
4. Agresearch Limited (1 from 31 patents)
5. University of Otago (1 from 14 patents)
6. The Malaghan Institute of Medical Research (1 from 3 patents)
7. Callaghan Innovation Research Limited (0 patent)
8. Regan James Anderson (0 patent)
9. Ian Francis Hermans (0 patent)
10. David Samuel Larsen (0 patent)
11. Benjamin Jason Compton (0 patent)
12. Colin Malcolm Hayman (0 patent)
13. Gavin Frank Painter (0 patent)
14. Franca Ronchese (0 patent)
11 patents:
1. 11072584 - Carbon monoxide releasing norbornenone compounds
2. 10494344 - Carbon monoxide releasing norbornenone compounds
3. 9764037 - Conjugate compounds
4. 9717790 - Sphingoglycolipid analogues
5. 9586985 - Organic compounds as proantigens for natural killer T cells
6. 8586585 - Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as Alzheimer's disease, type 2 diabetes and Parkinson's disease
7. 8163957 - Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes and parkinson's disease
8. 7989602 - Synthetic molecules having immune activity
9. 7763747 - Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease
10. 7601876 - Compounds, compositions and methods for the treatment of amyloid diseases such as systemic AA amyloidosis
11. 7514583 - Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease